This activity has expired. Thank you for using WebBasedCME.com. Continue to check our activities page for additional online CME offerings .


CME Demographic and Evaluation Form - Peak Issues (Issue 4): Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes

0. Have you created an account on WebBasedCME.com? You must register and be signed in to participate and receive CME credit for this activity.



1. Physicians: Are you licensed in the US?
Yes
No

2. What is your profession? Check all that apply.
MD
DO
RN
PA
  Other

3. Specialty
 

4. FACULTY AND CONTENT
Please rate the publication authors with respect to:
  Rating Scale: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent
 
(A): Knowledge of subject

1     2     3     4     5    
 
(B): Article content was orderly and understandable

1     2     3     4     5    

5. LEARNING OBJECTIVES
Please evaluate how well the following learning objectives were met:
  Rating Scale: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent
 
(A): Describe the role of incretin-based therapies in the management of hyperglycemia with particular focus on PPG and improvement of clinical outcomes

1     2     3     4     5    
 
(B): Compare and contrast the efficacy and safety of the dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes

1     2     3     4     5    
 
(C): Discuss the available evidence in the published guidelines and treatment algorithms pertaining to the importance of PPG monitoring for maintaining glycemic control

1     2     3     4     5    
 
(D): Explain how the mechanisms of action of the incretin-based therapies address the multi-factorial complexities of type 2 diabetes

1     2     3     4     5    

6. Was all data reported objectively and with appropriate referencing?
Yes
No

7. Was the overall content of this educational activity presented objectively and free of bias?
Yes
No

8. If you answered “No” to question 6 or 7, please explain:
 

9. Was the subject matter relevant to your clinical practice?
Yes
No

10. Was the educational format an effective learning method?
Yes
No

11. If you answered “No” to question 9 or 10, please explain:
 

12. What one question remains unanswered after having participated in this activity?
 

13. Cite one new piece of information learned from this activity.
 

14. What related topics would you like to have offered as future CME activities?
 

15. What are your preferred learning methods? (Check as many as applicable)
Live conferences
CD-ROM
Print materials (eg, monographs)
Internet/Web-based
PDA/Windows Mobile®/iPhone™
I do not want to receive further information regarding CaringForDiabetes activities
  Other

16. Additional Comments:
 

17. CME CREDIT ATTESTATION
The Institute for Medical and Nursing Education, Inc. (IMNE) designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

I certify that I completed this CME activity. The actual amount of time I spent in this activity was:
 
 hours     minutes  (Not to exceed 2 hr(s) )

 Enter your full name